Sequential Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide Is a Safe and Effective Regimen for the Treatment of Previously Treated and Untreated CLL/SLL: The Hilo Trial

被引：0

作者：

Pinilla-Ibarz, Javier ^{[1
]}

Chavez, Julio C. ^{[2
]}

Turba, Elyce

Nodzon, Lisa ^{[1
]}

Rock-Klotz, Jennifer ^{[3
]}

Dalia, Samir ^{[4
]}

Komrokji, Rami S. ^{[1
]}

Locke, Frederick L. ^{[5
]}

Kharfan-Dabaja, Mohamed A. ^{[6
]}

Bello, Celeste M. ^{[1
]}

机构：

[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL 33612 USA

[2] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Malignant Hematol, Tampa, FL 33682 USA

[3] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol, Tampa, FL 33612 USA

[4] Mercy Clin Oncol & Hematol, Joplin, MO USA

[5] Univ S Florida, H Lee Moffitt Canc Ctr, Blood & Marrow Transplantat, Tampa, FL 33682 USA

[6] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat, Tampa, FL 33612 USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 6 条

[1] SEQUENTIAL HIGH-DOSE ARA-C AND ASPARAGINASE IN THE THERAPY OF PREVIOUSLY TREATED AND UNTREATED PATIENTS WITH ACUTE-LEUKEMIA
CAPIZZI, RL
POWELL, BL
COOPER, MR
STUART, JJ
MUSS, HB
RICHARDS, F
JACKSON, DV
WHITE, DR
SPURR, CL
ZEKAN, PJ
CRUZ, JM
CRAIG, JB
SEMINARS IN ONCOLOGY, 1985, 12 (02) : 105 - 113
[2] Timed sequential therapy with high-dose cytarabine and mitoxantrone as an effective and safe induction regimen for acute myeloid leukemia.
Larson, Melissa L.
Burhani, Sakina
Gallas, Kirstin
Katz, Deborah Ann
Hoyt, Maura
Venugopal, Parameswaran
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[3] Obinutuzumab in combination with high-dose methylprednisolone and concurrent administration of lenalidomide. An effective non-chemotherapy regimen for the treatment of Richter's transformation
Amaya-Chanaga, Carlos I.
Choi, Michael Y.
Kipps, Thomas J.
Castro, Januario E.
LEUKEMIA & LYMPHOMA, 2015, 56 : 88 - 88
[4] SALVAGE TREATMENT WITH BENDAMUSTINE, OFATUMUMAB, HIGH-DOSE METHYLPREDNISOLONE (BOMP) IN HIGH-RISK R/R CLL: INTERIM RESULTS OF THE FRENCH CLL INTERGROUP (GCFLLC/MW - GOELAMS) ICLL01 PHASE 2 TRIAL.
de Guibert, S.
Dilhyudy, M. S.
Ysebaert, L.
Sanhes, L.
Choquet, S.
Aurran-Schleinitz, T.
Guieze, R.
Mahe, B.
Daguindau, N.
Araujo, C.
Saad, H.
Ferrant, E.
Cazin, B.
Feugier, P.
Dreyfus, B.
Delmer, A.
Lepretre, S.
Le Garff-Tavernier, M.
Veronese, L.
Nguyen-Khac, F.
Vilque, J. P.
Brion, A.
Dartigeas, C.
Dupuy, J.
Tiab, M.
Foussard, C.
Delepine, R.
Leblond, V.
Tournilhac, O.
HAEMATOLOGICA, 2014, 99 : 60 - 61
[5] Ofatumumab Combined with Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Results From a Randomized, Multicenter, International, Two-Dose, Parallel Group, Phase II Trial
Wierda, William G.
Kipps, Thomas J.
Duerig, Jan
Griskevicius, Laimonas
Stilgenbauer, Stephan
Mayer, Jiri
Smolej, Lukas
Hess, Georg
Griniute, Rasa
Hernandez-Ilizaliturri, Francisco J.
Padmanabhan, Swaminathan
Gorczyca, Michele
Chan, Geoffrey
Gupta, Ira
Andersen, Marc
Strange, Claus
Nielsen, Tina G.
Russell, Charlotte A.
BLOOD, 2009, 114 (22) : 90 - 91
[6] Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
Xie, Yong
Zhu, Zhenhua
Wang, Jiangbin
Zhang, Lingxia
Zhang, Zhenyu
Lu, Hong
Zeng, Zhirong
Chen, Shiyao
Liu, Dongsheng
Lv, Nonghua
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (09)

← 1 →